Advertisement
Mayo Clinic Proceedings Home

Peripheral Artery Disease and Subsequent Risk of Infectious Disease in Older Individuals: The ARIC Study

Published:October 07, 2022DOI:https://doi.org/10.1016/j.mayocp.2022.03.038

      Abstract

      Objective

      To quantify the association of peripheral artery disease (PAD) with infection risk because PAD has been understudied despite recognition of atherosclerotic cardiovascular disease as a risk factor for infection.

      Methods

      Among 5082 participants of the Atherosclerosis Risk in Communities study (aged 71 to 90 years during 2011-2013), we assessed the association of PAD status, based on clinical history and ankle-brachial index (ABI), with infection-related hospitalization (through December 2019) using multivariable Cox regression. We also cross-classified participants by PAD and coronary heart disease (CHD)/stroke status at baseline, with implications for polyvascular disease.

      Results

      During the median follow-up of 6.5 years, there were 1677 infection-related hospitalizations. Peripheral artery disease (clinical history or ABI ≤0.90) was independently associated with the risk of overall infection (adjusted hazard ratio [HR], 1.66 [95% CI, 1.42 to 1.94] vs ABI of 1.11 to 1.20), as was borderline low ABI of 0.91 to 1.00 (adjusted HR, 1.75 [95% CI, 1.47 to 2.07]). Results were consistent across major types of infection (ie, cellulitis, bloodstream infection, pneumonia, and urinary tract infection). For overall infection, PAD plus CHD/stroke had the highest HR of hospitalized infection (1.9), and PAD alone and CHD/stroke alone showed similar HRs of 1.6. For subtypes of infection, PAD alone had the highest HR of approximately 2 for bloodstream infection; PAD alone and PAD plus CHD/stroke had a similar risk of urinary tract infection with HR of approximately 1.7.

      Conclusion

      Peripheral artery disease and borderline low ABI were robustly associated with infection-related hospitalization of older adults. The contribution of PAD to infection risk was comparable to that of CHD/stroke, warranting clinical attention to PAD for the prevention of infectious diseases.

      Abbreviations and Acronyms:

      ABI (ankle-brachial index), ARIC (Atherosclerosis Risk in Communities), ASCVD (atherosclerotic cardiovascular disease), CHD (coronary heart disease), HR (hazard ratio), hs-CRP (high-sensitivity C-reactive protein), PAD (peripheral artery disease)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Mayo Clinic Proceedings
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Torres A.
        • Blasi F.
        • Dartois N.
        • Akova M.
        Which individuals are at increased risk of pneumococcal disease and why? Impact of COPD, asthma, smoking, diabetes, and/or chronic heart disease on community-acquired pneumonia and invasive pneumococcal disease.
        Thorax. 2015; 70: 984-989
        • Koivula I.
        • Sten M.
        • Makela P.H.
        Risk factors for pneumonia in the elderly.
        Am J Med. 1994; 96: 313-320
        • Almirall J.
        • Bolibar I.
        • Serra-Prat M.
        • et al.
        New evidence of risk factors for community-acquired pneumonia: a population-based study.
        Eur Respir J. 2008; 31: 1274-1284
        • Jackson M.L.
        • Nelson J.C.
        • Jackson L.A.
        Risk factors for community-acquired pneumonia in immunocompetent seniors.
        J Am Geriatr Soc. 2009; 57: 882-888
        • van Hoek A.J.
        • Andrews N.
        • Waight P.A.
        • et al.
        The effect of underlying clinical conditions on the risk of developing invasive pneumococcal disease in England.
        J Infect. 2012; 65: 17-24
        • Gurfinkel E.P.
        • Leon de la Fuente R.
        • Mendiz O.
        • Mautner B.
        Flu vaccination in acute coronary syndromes and planned percutaneous coronary interventions (FLUVACS) Study.
        Eur Heart J. 2004; 25: 25-31
        • Ciszewski A.
        • Bilinska Z.T.
        • Brydak L.B.
        • et al.
        Influenza vaccination in secondary prevention from coronary ischaemic events in coronary artery disease: FLUCAD study.
        Eur Heart J. 2008; 29: 1350-1358
        • Phrommintikul A.
        • Kuanprasert S.
        • Wongcharoen W.
        • Kanjanavanit R.
        • Chaiwarith R.
        • Sukonthasarn A.
        Influenza vaccination reduces cardiovascular events in patients with acute coronary syndrome.
        Eur Heart J. 2011; 32: 1730-1735
        • Clar C.
        • Oseni Z.
        • Flowers N.
        • Keshtkar-Jahromi M.
        • Rees K.
        Influenza vaccines for preventing cardiovascular disease.
        Cochrane Database Syst Rev. 2015; 2015: CD005050https://doi.org/10.1002/14651858.CD005050.pub3
        • Lam F.
        • Chen T.L.
        • Shih C.C.
        • et al.
        Protective effect of influenza vaccination on outcomes in geriatric stroke patients: a nationwide matched cohort study.
        Atherosclerosis. 2019; 282: 85-90
        • Ochoa-Gondar O.
        • Vila-Corcoles A.
        • Rodriguez-Blanco T.
        • et al.
        Evaluating the clinical effectiveness of pneumococcal vaccination in preventing myocardial infarction: the CAPAMIS study, three-year follow-up.
        Vaccine. 2014; 32: 252-257
        • Davis M.M.
        • Taubert K.
        • Benin A.L.
        • et al.
        Influenza vaccination as secondary prevention for cardiovascular disease: a science advisory from the American Heart Association/American College of Cardiology.
        J Am Coll Cardiol. 2006; 48 (Published correction appears in J Am Coll Cardiol. 2006;48(12):2610): 1498-1502
        • Smith Jr., S.C.
        • Benjamin E.J.
        • Bonow R.O.
        • et al.
        AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation.
        Circulation. 2011; 124 (Published correction appears in Circulation. 2015;131(15):e408): 2458-2473
        • Perk J.
        • De Backer G.
        • Gohlke H.
        • et al.
        European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts).
        Atherosclerosis. 2012; 223: 1-68
        • Williams W.W.
        • Lu P.J.
        • O'Halloran A.
        • et al.
        Vaccination coverage among adults, excluding influenza vaccination—United States, 2013.
        MMWR Morb Mortal Wkly Rep. 2015; 64: 95-102
        • Gerhard-Herman M.D.
        • Gornik H.L.
        • Barrett C.
        • et al.
        2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
        J Am Coll Cardiol. 2017; 69 (Published correction appears in J Am Coll Cardiol. 2017;69(11):1521): e71-e126
        • Kolte D.
        • Kennedy K.F.
        • Shishehbor M.H.
        • et al.
        Thirty-day readmissions after endovascular or surgical therapy for critical limb ischemia: analysis of the 2013 to 2014 Nationwide Readmissions Databases.
        Circulation. 2017; 136: 167-176
        • Secemsky E.A.
        • Schermerhorn M.
        • Carroll B.J.
        • et al.
        Readmissions after revascularization procedures for peripheral arterial disease: a nationwide cohort study.
        Ann Intern Med. 2018; 168: 93-99
        • Melvin J.C.
        • Smith J.B.
        • Kruse R.L.
        • Vogel T.R.
        Risk factors for 30-day hospital re-admission with an infectious complication after lower-extremity vascular procedures.
        Surg Infect (Larchmt). 2017; 18: 319-326
        • Bodewes T.C.
        • Soden P.A.
        • Ultee K.H.
        • et al.
        Risk factors for 30-day unplanned readmission following infrainguinal endovascular interventions.
        J Vasc Surg. 2017; 65: 484-494.e3
        • Wang H.E.
        • Shapiro N.I.
        • Griffin R.
        • Safford M.M.
        • Judd S.
        • Howard G.
        Chronic medical conditions and risk of sepsis.
        PLoS One. 2012; 7e48307
        • Weatherley B.D.
        • Nelson J.J.
        • Heiss G.
        • et al.
        The association of the ankle-brachial index with incident coronary heart disease: the Atherosclerosis Risk In Communities (ARIC) study, 1987-2001.
        BMC Cardiovasc Disord. 2007; 7: 3
        • Leng G.C.
        • Fowkes F.G.
        • Lee A.J.
        • Dunbar J.
        • Housley E.
        • Ruckley C.V.
        Use of ankle brachial pressure index to predict cardiovascular events and death: a cohort study.
        BMJ. 1996; 313: 1440-1444
        • Jukema J.W.
        • Szarek M.
        • Zijlstra L.E.
        • et al.
        Alirocumab in Patients with polyvascular disease and recent acute coronary syndrome: ODYSSEY OUTCOMES trial.
        J Am Coll Cardiol. 2019; 74: 1167-1176
      1. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators.
        Am J Epidemiol. 1989; 129: 687-702
        • Matsushita K.
        • Ballew S.H.
        • Sang Y.
        • et al.
        Ankle-brachial index and physical function in older individuals: the Atherosclerosis Risk in Communities (ARIC) study.
        Atherosclerosis. 2017; 257: 208-215
        • Hirsch A.T.
        • Haskal Z.J.
        • Hertzer N.R.
        • et al.
        ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation.
        Circulation. 2006; 113: e463-654
        • Matsushita K.
        • Kwak L.
        • Yang C.
        • et al.
        High-sensitivity cardiac troponin and natriuretic peptide with risk of lower-extremity peripheral artery disease: the Atherosclerosis Risk in Communities (ARIC) study.
        Eur Heart J. 2018; 39: 2412-2419
        • Cowan L.T.
        • Lutsey P.L.
        • Pankow J.S.
        • Matsushita K.
        • Ishigami J.
        • Lakshminarayan K.
        Inpatient and outpatient infection as a trigger of cardiovascular disease: the ARIC study.
        J Am Heart Assoc. 2018; 7e009683
        • Christensen K.L.
        • Holman R.C.
        • Steiner C.A.
        • Sejvar J.J.
        • Stoll B.J.
        • Schonberger L.B.
        Infectious disease hospitalizations in the United States.
        Clin Infect Dis. 2009; 49: 1025-1035
        • Fowkes F.G.
        • Murray G.D.
        • Butcher I.
        • et al.
        • Ankle Brachial Index Collaboration
        Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis.
        JAMA. 2008; 300: 197-208
        • Wang F.M.
        • Yang C.
        • Ballew S.H.
        • et al.
        Ankle-brachial index and subsequent risk of incident and recurrent cardiovascular events in older adults: the Atherosclerosis Risk in Communities (ARIC) study.
        Atherosclerosis. 2021; 336: 39-47
        • Bonaca M.P.
        • Nault P.
        • Giugliano R.P.
        • et al.
        Low-density lipoprotein cholesterol lowering with evolocumab and outcomes in patients with peripheral artery disease: insights from the FOURIER trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk).
        Circulation. 2018; 137: 338-350
        • Pencina M.J.
        • D'Agostino R.B.
        Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation.
        Stat Med. 2004; 23: 2109-2123
        • Wang H.E.
        • Shapiro N.I.
        • Safford M.M.
        • et al.
        High-sensitivity C-reactive protein and risk of sepsis.
        PLoS One. 2013; 8e69232
        • Wolf D.
        • Ley K.
        Immunity and inflammation in atherosclerosis.
        Circ Res. 2019; 124: 315-327
        • Meng X.
        • Yang J.
        • Dong M.
        • et al.
        Regulatory T cells in cardiovascular diseases.
        Nat Rev Cardiol. 2016; 13: 167-179
        • Benfield T.
        • Jensen J.S.
        • Nordestgaard B.G.
        Influence of diabetes and hyperglycaemia on infectious disease hospitalisation and outcome.
        Diabetologia. 2007; 50: 549-554
        • Dryden M.
        • Baguneid M.
        • Eckmann C.
        • et al.
        Pathophysiology and burden of infection in patients with diabetes mellitus and peripheral vascular disease: focus on skin and soft-tissue infections.
        Clin Microbiol Infect. 2015; 21: S27-S32
        • Shah B.R.
        • Hux J.E.
        Quantifying the risk of infectious diseases for people with diabetes.
        Diabetes Care. 2003; 26: 510-513
        • Huttunen R.
        • Heikkinen T.
        • Syrjanen J.
        Smoking and the outcome of infection.
        J Intern Med. 2011; 269: 258-269
        • Aziz F.
        • Lehman E.
        • Blebea J.
        • Lurie F.
        Postoperative complications after lower extremity arterial bypass increase the risk of new deep venous thrombosis.
        Phlebology. 2018; 33: 558-566
        • Daryapeyma A.
        • Ostlund O.
        • Wahlgren C.M.
        Healthcare-associated infections after lower extremity revascularization.
        Eur J Vasc Endovasc Surg. 2014; 48: 72-77
        • Nicolle L.E.
        Urinary tract infections in the older adult.
        Clin Geriatr Med. 2016; 32: 523-538
        • O'Hare A.M.
        • Katz R.
        • Shlipak M.G.
        • Cushman M.
        • Newman A.B.
        Mortality and cardiovascular risk across the ankle-arm index spectrum: results from the Cardiovascular Health Study.
        Circulation. 2006; 113: 388-393
        • Resnick H.E.
        • Lindsay R.S.
        • McDermott M.M.
        • et al.
        Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality: the Strong Heart Study.
        Circulation. 2004; 109: 733-739
        • McDermott M.M.
        • Liu K.
        • Criqui M.H.
        • et al.
        Ankle-brachial index and subclinical cardiac and carotid disease: the Multi-Ethnic Study of Atherosclerosis.
        Am J Epidemiol. 2005; 162: 33-41
        • Allison M.A.
        • Hiatt W.R.
        • Hirsch A.T.
        • Coll J.R.
        • Criqui M.H.
        A high ankle-brachial index is associated with increased cardiovascular disease morbidity and lower quality of life.
        J Am Coll Cardiol. 2008; 51: 1292-1298
        • McDermott M.M.
        • Guralnik J.M.
        • Tian L.
        • et al.
        Associations of borderline and low normal ankle-brachial index values with functional decline at 5-year follow-up: the WALCS (Walking and Leg Circulation Study).
        J Am Coll Cardiol. 2009; 53: 1056-1062
        • Korhonen P.
        • Aarnio P.
        Borderline peripheral arterial disease.
        Int J Angiol. 2008; 17: 175-177
        • Grohskopf L.A.
        • Sokolow L.Z.
        • Broder K.R.
        • et al.
        Prevention and control of seasonal influenza with vaccines.
        MMWR Recomm Rep. 2016; 65: 1-54
        • Black C.L.
        • Yue X.
        • Ball S.W.
        • et al.
        Influenza vaccination coverage among health care personnel—United States, 2013-14 influenza season.
        MMWR Morb Mortal Wkly Rep. 2014; 63: 805-811
        • Centers for Disease Control and Prevention
        Flu vaccination coverage, United States, 2019-20 influenza season.
        (Accessed June 8, 2021.)
        • Aboyans V.
        • Criqui M.H.
        • Abraham P.
        • et al.
        Measurement and interpretation of the ankle-brachial index: a scientific statement from the American Heart Association.
        Circulation. 2012; 126 (Published correction appears in Circulation. 2013;127(1):e264): 2890-2909
        • Liang L.
        • Moore B.
        • Soni A.
        National inpatient hospital costs: the most expensive conditions by payer, 2017: Statistical Brief #261.
        in: Healthcare Cost and Utilization Project (HCUP) Statistical Briefs [Internet]. Agency for Healthcare Research and Quality, 2006
        https://www.ncbi.nlm.nih.gov/books/NBK561141
        Date accessed: September 24, 2020
        • Schneeweiss S.
        • Robicsek A.
        • Scranton R.
        • Zuckerman D.
        • Solomon D.H.
        Veteran's Affairs hospital discharge databases coded serious bacterial infections accurately.
        J Clin Epidemiol. 2007; 60: 397-409
        • Drahos J.
        • Vanwormer J.J.
        • Greenlee R.T.
        • Landgren O.
        • Koshiol J.
        Accuracy of ICD-9-CM codes in identifying infections of pneumonia and herpes simplex virus in administrative data.
        Ann Epidemiol. 2013; 23: 291-293